A team of experts to tackle challenges in inhalation drug delivery

Dr. Elijah Nazarzadeh has led Nebu-Flow®’s technology and business development through his postdoctoral research at the University of Glasgow. Elijah started the business development by securing an Innovate UK’s ICURe programme  and was subsequently awarded an Unlocking Ambition Fellowship, supported by the Scottish Government, from the Royal Society of Edinburgh.

Dr. John Pritchard has more than 25 years of experience in the field working for GSK, AstraZeneca, 3M and Philips. He received the Charles Thiel Award from Virginia Commonwealth University for outstanding research and discovery in respiratory drug delivery in 2018.

Professor Beaumont is a Director of Nebu-Flow®. Steve is a Chartered Engineer, a Fellow of the Royal Society of Edinburgh and Fellow of the Royal Academy of Engineering. He has significant experience in developing spin-out companies.

Harry is the founder of the Science Creates ecosystem and Managing Partner of Science Creates Ventures. He is a scientist, entrepreneur and investor, and the co-founder of Ziylo, the hugely successful University of Bristol spin-out company. Harry is passionate about building great companies and providing the optimum ecosystem to facilitate their growth and development.

Anastasia is an Investment Manager at Foresight Group. Prior to joining Foresight, Anastasia worked at the private equity arm of EBRD and a lower mid-market private equity fund focusing on tech, tech-enabled and generalist investments. Anastasia holds an MSc in Corporate Finance from Bayes Business School (former Cass Business School) and a BSc in Business Administration from the University of Economics in Prague.

Professor Cooper has already spun successful companies from his research, including Mode-Dx (who signed an agreement with Boots covering bowel cancer diagnostics) and Clyde Biosciences (developing drug screening with three pharmaceutical companies).

Dr Gary Pitcairn is an experienced senior leader, with a successful track record of leading global multidisciplinary teams. Gary is a recognised expert in the field of inhaled drug delivery with extensive device experience in both nebulisers and inhalers. Gary also has proven product development experience, from pre-clinical through to late phase.

Dr. Helen Erwood, Director of ESPL, has nearly 30 years of experience in regulatory affairs working for ICI Pharmaceuticals (now Astra-Zeneca), Rhone Poulenc Rorer (now Sanofi Aventis) and SmithKline Beecham Consumer Healthcare (now GSK Consumer).

Dr. Helen Muirhead is a Fellow of the Royal Society of Chemistry with 42 years of experience of both R&D and Manufacturing, including 30 years at GSK. Helen headed up the Respiratory Centre of Excellence during the late stages of Product Development through Regulatory Filing and Commercial Launch and supply of new Medicines.

Dr. Julien Reboud, a co-founder of Nebu-Flow®, is Senior Lecturer at the University of Glasgow. He is joint winner of the Royal Academy of Engineering ERA Foundation Entrepreneurs Award. Julien brings a long track record of research and application of the SAW technology.

Prof. Dr. Gordon Muirhead has more than 20 years of experience in senior roles at GlaxoSmithKline (GSK) including 12 years as Vice President of Global New Medicines Introduction within the Global Manufacturing and Supply division of GSK.

Awadhesh is an accomplished Engineering Project Manager with over 8 years of experience in R&D engineering and product development. With a strong background in highly scientific laboratory and medical devices, Awadhesh brings a wealth of expertise to the table. His qualifications include an MBA in Strategy & FinTech, an MSc in Data Science, PGD in Business Analyst and a B. Tech in Electrical and Electronics Engineering. Awadhesh has successfully led teams of engineers and researchers, managing projects from start to finish while resolving technical and non-technical issues. His skills encompass strategic planning, project management, data analytics, and problem-solving.

Christian earned a PhD in Biomedical Engineering from the University of Glasgow and a Masters degree in Biosystems Technology and Bioinformatics from the Technical University of Applied Sciences Wildau, Germany. His research expertise includes biosensor technologies and the application of acoustofluidic and electrokinetic phenomena for micro and nano-scale manipulations. As a valued member of the Nebu-Flow® team, he utilizes his knowledge to develop the core technology and navigate the complex regulatory landscape of medical device development.

David completed his PhD at University of Exeter, where he studied the thermoacoustic generation of ultrasound via Joule heating in thin films. In particular, he demonstrated how the unique characteristics of such sound sources make them ideal for application in ultrasonic phased arrays.

Graham brings 20 years of experience working in the field of aerosol drug delivery. Much of this time has been spent establishing collaborations with pharma companies, supporting the evaluations of potential delivery devices with their drug and supplying products for both clinical trials and commercially.

Habib got his Bachelors degree in Electronics and Communications Engineering from the University of York and his Masters degree in Biomedical Engineering from the University of Glasgow. He has a PhD in Electronics and Electrical Engineering from the University of Glasgow where he developed novel embedded electronic systems for affordable, user-centred, and environmentally sustainable biomedical devices.

Rabeeah is a Mechanical Engineer with a PhD from the University of Glasgow. His PhD research has been published in five journal articles and presented at the 16th UK National Heat Transfer conference held at the University of Nottingham in 2019. Rabeeah is passionate about using his skills to make a difference, evident in his latest research project at the Queen Mary University of London on the RELIANT COVID-19 related project, which focused on evaluating the risk of infection in indoor environments.